Vault-13

VIKING GLOBAL INVESTORS LP

STAMFORD, CT · CIK 1103804 · 13F filing filed 2023-08-14

SEC-registered investment adviser since 2011 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Stamford, CT (main office)United States United Statesabout 7
New York, NYUnited States United States69
San Francisco, CAUnited States United States1

US visa salary filings

Job titleFilingsMedianRange
Head Of Portfolio Finance (Liquid)New York, NY 1 $350,000
Senior Analyst, Public InvestmentNew York, NY 1 $250,000
Senior Analyst - Performance AnalyticsNew York, NY 1 $200,000
Business Intelligence & Performance Analytics Sr. DeveloperStamford, CT 1 $195,000
Network EngineerNew York, NY 1 $175,000 $175,000 – $225,000
Data ScientistNew York, NY 1 $175,000
Investment AnalystNew York, NY 1 $175,000
Sr. Tax Compliance SpecialistStamford, CT 1 $160,000 $160,000 – $190,000
Data EngineerNew York, NY 1 $150,000 $150,000 – $200,000
Policy Research AssociateNew York, NY 1 $120,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Viking Global Investors LP.

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$24.4bn reported value +14.6% vs Q1 2023
86positions
37.3%in top 10
21 new 27 added 27 reduced 16 sold out vs Q1 2023

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VISA INC COM CL A V V 7,140,286 $1.7bn6.94% 6.94% AddedShares held: Q3 2022 5.3m, Q4 2022 5.8m, Q1 2023 6.6m, Q2 2023 7.1m +580.2k +580,217 8.8%
2 DANAHER CORPORATION COM DHR DHR 4,256,761 $1.0bn4.18% 4.18% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 4.3m
3 API GROUP CORP COM STK APG APG 34,199,532 $932.3m3.82% 3.82% AddedShares held: Q3 2022 33.8m, Q4 2022 33.8m, Q1 2023 34.1m, Q2 2023 34.2m +109.2k +109,247 0.3%
4 PHILIP MORRIS INTL INC COM PM PM 9,055,492 $884.0m3.62% 3.62% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 9.1m
5 UNITEDHEALTH GROUP INC COM UNH UNH 1,794,275 $862.4m3.53% 3.53% ReducedShares held: Q3 2022 348.6k, Q4 2022 1.3m, Q1 2023 2.1m, Q2 2023 1.8m -305.7k -305,716 -14.6%
6 GE AEROSPACE COM NEW GE GE 7,138,176 $784.1m3.21% 3.21% ReducedShares held: Q3 2022 12.9m, Q4 2022 7.8m, Q1 2023 8.6m, Q2 2023 7.1m -1.5m -1,474,056 -17.1%
7 ROIVANT SCIENCES LTD SHS ROIV ROIV 75,238,700 $758.4m3.10% 3.10% ReducedShares held: Q3 2022 88.2m, Q4 2022 88.2m, Q1 2023 88.2m, Q2 2023 75.2m -13.0m -13,000,000 -14.7%
8 META PLATFORMS INC CL A META META 2,594,548 $744.6m3.05% 3.05% ReducedShares held: Q3 2022 5.4m, Q4 2022 2.4m, Q1 2023 3.2m, Q2 2023 2.6m -635.4k -635,366 -19.7%
9 FORTIVE CORP COM FTV FTV 9,798,229 $732.6m3.00% 3.00% AddedShares held: Q3 2022 6.1m, Q4 2022 3.9m, Q1 2023 6.3m, Q2 2023 9.8m +3.5m +3,451,701 54.4%
10 WORKDAY INC CL A WDAY WDAY 3,038,619 $686.4m2.81% 2.81% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 642.4k, Q2 2023 3.0m +2.4m +2,396,172 373.0%
11 HDFC BANK LTD SPONSORED ADS HDB HDB 9,312,208 $649.1m2.66% 2.66% AddedShares held: Q3 2022 9.7m, Q4 2022 8.6m, Q1 2023 8.3m, Q2 2023 9.3m +1.0m +1,026,581 12.4%
12 ELEVANCE HEALTH INC COM ELV ELV 1,412,701 $627.6m2.57% 2.57% ReducedShares held: Q3 2022 2.3m, Q4 2022 1.9m, Q1 2023 2.2m, Q2 2023 1.4m -741.9k -741,855 -34.4%
13 SHERWIN WILLIAMS CO COM SHW SHW 2,274,718 $604.0m2.47% 2.47% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.3m, Q2 2023 2.3m +22.7k +22,658 1.0%
14 FORTINET INC COM FTNT FTNT 7,689,287 $581.2m2.38% 2.38% ReducedShares held: Q3 2022 0, Q4 2022 7.1m, Q1 2023 11.9m, Q2 2023 7.7m -4.2m -4,186,097 -35.2%
15 AMAZON COM INC COM AMZN AMZN 4,401,313 $573.8m2.35% 2.35% ReducedShares held: Q3 2022 9.3m, Q4 2022 12.5m, Q1 2023 7.6m, Q2 2023 4.4m -3.2m -3,226,907 -42.3%
16 INTUIT COM INTU INTU 1,053,352 $482.6m1.98% 1.98% ReducedShares held: Q3 2022 1.2m, Q4 2022 1.2m, Q1 2023 1.2m, Q2 2023 1.1m -167.7k -167,742 -13.7%
17 BRIDGEBIO PHARMA INC COM BBIO BBIO 26,620,991 $457.9m1.87% 1.87% UnchangedShares held: Q3 2022 26.6m, Q4 2022 26.6m, Q1 2023 26.6m, Q2 2023 26.6m
18 LULULEMON ATHLETICA INC COM LULU LULU 1,189,594 $450.3m1.84% 1.84% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.9m, Q2 2023 1.2m -704.3k -704,289 -37.2%
19 CSX CORP COM CSX CSX 12,806,951 $436.7m1.79% 1.79% ReducedShares held: Q3 2022 0, Q4 2022 15.5m, Q1 2023 22.1m, Q2 2023 12.8m -9.3m -9,250,168 -41.9%
20 THERMO FISHER SCIENTIFIC INC COM TMO TMO 833,233 $434.7m1.78% 1.78% ReducedShares held: Q3 2022 593.5k, Q4 2022 839.5k, Q1 2023 856.8k, Q2 2023 833.2k -23.6k -23,603 -2.8%
21 CADENCE DESIGN SYSTEM INC COM CDNS CDNS 1,750,247 $410.5m1.68% 1.68% AddedShares held: Q3 2022 605.5k, Q4 2022 1.1m, Q1 2023 1.2m, Q2 2023 1.8m +524.9k +524,941 42.8%
22 MICROSOFT CORP COM MSFT MSFT 1,202,051 $409.3m1.68% 1.68% AddedShares held: Q3 2022 3.5m, Q4 2022 3.4m, Q1 2023 1.0m, Q2 2023 1.2m +154.7k +154,699 14.8%
23 MASTERCARD INCORPORATED CL A MA MA 1,012,725 $398.3m1.63% 1.63% AddedShares held: Q3 2022 1.8m, Q4 2022 1.7m, Q1 2023 796.7k, Q2 2023 1.0m +216.0k +215,985 27.1%
24 AMERIPRISE FINL INC COM AMP AMP 1,124,103 $373.4m1.53% 1.53% AddedShares held: Q3 2022 1.8m, Q4 2022 1.6m, Q1 2023 941.0k, Q2 2023 1.1m +183.1k +183,063 19.4%
25 CBRE GROUP INC CL A CBRE CBRE 4,578,096 $369.5m1.51% 1.51% NewShares held: Q3 2022 409.7k, Q4 2022 0, Q1 2023 0, Q2 2023 4.6m
26 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 4,156,785 $360.3m1.48% 1.48% AddedShares held: Q3 2022 5.1m, Q4 2022 5.3m, Q1 2023 2.2m, Q2 2023 4.2m +2.0m +1,988,168 91.7%
27 EVEREST GROUP LTD COM EG EG 1,038,182 $354.9m1.45% 1.45% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.0m
28 ARISTA NETWORKS INC COM COM 2,036,587 $330.0m1.35% 1.35% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.0m
29 ROYALTY PHARMA PLC SHS CLASS A RPRX RPRX 9,850,932 $302.8m1.24% 1.24% ReducedShares held: Q3 2022 10.9m, Q4 2022 10.0m, Q1 2023 11.2m, Q2 2023 9.9m -1.4m -1,353,317 -12.1%
30 VALVOLINE INC COM VVV VVV 7,682,814 $288.2m1.18% 1.18% AddedShares held: Q3 2022 5.8m, Q4 2022 4.9m, Q1 2023 7.4m, Q2 2023 7.7m +284.1k +284,101 3.8%
31 INTERNATIONAL FLAVORS&FRAGRA COM IFF IFF 3,569,966 $284.1m1.16% 1.16% AddedShares held: Q3 2022 3.7m, Q4 2022 439.4k, Q1 2023 812.7k, Q2 2023 3.6m +2.8m +2,757,286 339.3%
32 MICRON TECHNOLOGY INC COM MU MU 4,424,339 $279.2m1.14% 1.14% AddedShares held: Q3 2022 5.4m, Q4 2022 8.4m, Q1 2023 2.9m, Q2 2023 4.4m +1.6m +1,567,740 54.9%
33 NETFLIX INC COM NFLX NFLX 630,865 $277.9m1.14% 1.14% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 630.9k
34 COUPANG INC CL A CPNG CPNG 15,315,205 $266.5m1.09% 1.09% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 7.4m, Q2 2023 15.3m +7.9m +7,893,752 106.4%
35 GINKGO BIOWORKS HOLDINGS INC CL A SHS CL A SHS 143,085,126 $266.1m1.09% 1.09% UnchangedShares held: Q3 2022 101.8m, Q4 2022 63.1m, Q1 2023 143.1m, Q2 2023 143.1m
36 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 3,240,894 $258.1m1.06% 1.06% ReducedShares held: Q3 2022 3.0m, Q4 2022 3.2m, Q1 2023 3.4m, Q2 2023 3.2m -113.2k -113,216 -3.4%
37 UNUM GROUP COM UNM UNM 5,271,387 $251.4m1.03% 1.03% AddedShares held: Q3 2022 5.1m, Q4 2022 3.4m, Q1 2023 4.3m, Q2 2023 5.3m +1.0m +1,017,974 23.9%
38 MCKESSON CORP COM MCK MCK 524,143 $224.0m0.92% 0.92% ReducedShares held: Q3 2022 2.6m, Q4 2022 2.2m, Q1 2023 3.2m, Q2 2023 524.1k -2.7m -2,682,937 -83.7%
39 DOORDASH INC CL A DASH DASH 2,700,350 $206.4m0.84% 0.84% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.7m
40 KARUNA THERAPEUTICS INC COM COM 947,955 $205.6m0.84% 0.84% ReducedShares held: Q3 2022 1.0m, Q4 2022 1.2m, Q1 2023 1.5m, Q2 2023 948.0k -553.1k -553,119 -36.9%
41 ADAPTIVE BIOTECHNOLOGIES COR COM ADPT ADPT 29,993,708 $201.3m0.82% 0.82% UnchangedShares held: Q3 2022 30.0m, Q4 2022 30.0m, Q1 2023 30.0m, Q2 2023 30.0m
42 SEAGATE TECHNOLOGY HLDNGS PL ORD SHS STX STX 3,186,400 $197.1m0.81% 0.81% ReducedShares held: Q3 2022 0, Q4 2022 6.2m, Q1 2023 5.5m, Q2 2023 3.2m -2.3m -2,327,557 -42.2%
43 CHUBB LIMITED COM CB CB 970,942 $187.0m0.77% 0.77% ReducedShares held: Q3 2022 3.6m, Q4 2022 3.6m, Q1 2023 3.5m, Q2 2023 970.9k -2.5m -2,495,798 -72.0%
44 GALLAGHER ARTHUR J & CO COM AJG AJG 822,515 $180.6m0.74% 0.74% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 822.5k
45 FIVE9 INC COM FIVN FIVN 2,169,587 $178.9m0.73% 0.73% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 2.2m
46 INHIBRX INC COM INBX INBX 6,639,199 $172.4m0.71% 0.71% UnchangedShares held: Q3 2022 5.3m, Q4 2022 6.6m, Q1 2023 6.6m, Q2 2023 6.6m
47 EPAM SYS INC COM EPAM EPAM 764,907 $171.9m0.70% 0.70% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 764.9k
48 EMERSON ELEC CO COM EMR EMR 1,901,470 $171.9m0.70% 0.70% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.4m, Q2 2023 1.9m -499.4k -499,409 -20.8%
49 UNITED PARCEL SERVICE INC CL B UPS UPS 889,190 $159.4m0.65% 0.65% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 889.2k
50 SYNOPSYS INC COM SNPS SNPS 310,608 $135.2m0.55% 0.55% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 205.0k, Q2 2023 310.6k +105.6k +105,576 51.5%
51 PPG INDS INC COM PPG PPG 900,018 $133.5m0.55% 0.55% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 900.0k
52 NVIDIA CORPORATION COM NVDA NVDA 312,400 $132.2m0.54% 0.54% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 312.4k
53 COLGATE PALMOLIVE CO COM CL CL 1,238,533 $95.4m0.39% 0.39% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 660.7k, Q2 2023 1.2m +577.8k +577,835 87.5%
54 CONSTELLATION ENERGY CORP COM CEG CEG 1,041,072 $95.3m0.39% 0.39% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.0m, Q2 2023 1.0m -1.0m -1,006,616 -49.2%
55 RIVIAN AUTOMOTIVE INC COM CL A RIVN RIVN 5,433,046 $90.5m0.37% 0.37% AddedShares held: Q3 2022 1.6m, Q4 2022 0, Q1 2023 5.3m, Q2 2023 5.4m +182.6k +182,629 3.5%
56 DATADOG INC CL A COM DDOG DDOG 879,878 $86.6m0.35% 0.35% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 879.9k
57 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 4,787,914 $86.5m0.35% 0.35% AddedShares held: Q3 2022 3.9m, Q4 2022 3.9m, Q1 2023 3.9m, Q2 2023 4.8m +850.0k +850,000 21.6%
58 GUARDANT HEALTH INC NOTE 11/1 · principal GH 0 11.15.27 · principal GH 0 11.15.27 120,000,000 $86.4m0.35% 0.35% UnchangedPrincipal held: Q3 2022 120.0m, Q4 2022 120.0m, Q1 2023 120.0m, Q2 2023 120.0m
59 KENVUE INC COM KVUE KVUE 3,141,799 $83.0m0.34% 0.34% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 3.1m
60 ROGERS COMMUNICATIONS INC CL B RCI RCI 1,764,200 $80.5m0.33% 0.33% ReducedShares held: Q3 2022 3.4m, Q4 2022 4.4m, Q1 2023 5.6m, Q2 2023 1.8m -3.8m -3,790,300 -68.2%
61 KBR INC COM KBR KBR 1,203,207 $78.3m0.32% 0.32% ReducedShares held: Q3 2022 0, Q4 2022 1.1m, Q1 2023 1.7m, Q2 2023 1.2m -476.3k -476,267 -28.4%
62 ALIBABA GROUP HLDG LTD SPONSORED ADS BABA BABA 932,407 $77.7m0.32% 0.32% NewShares held: Q3 2022 1.2m, Q4 2022 0, Q1 2023 0, Q2 2023 932.4k
63 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 6,524,565 $77.6m0.32% 0.32% AddedShares held: Q3 2022 0, Q4 2022 3.8m, Q1 2023 3.9m, Q2 2023 6.5m +2.6m +2,608,695 66.6%
64 XPO INC COM XPO XPO 1,281,240 $75.6m0.31% 0.31% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.3m
65 ZAI LAB LTD ADR ZLAB ZLAB 2,629,445 $72.9m0.30% 0.30% AddedShares held: Q3 2022 2.6m, Q4 2022 2.0m, Q1 2023 2.3m, Q2 2023 2.6m +298.2k +298,200 12.8%
66 NEW RELIC INC COM NEWR NEWR 1,098,858 $71.9m0.29% 0.29% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.1m
67 CNH INDL N V SHS CNH CNH 4,766,168 $68.6m0.28% 0.28% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.8m, Q2 2023 4.8m +1.9m +1,938,653 68.6%
68 ALKERMES PLC SHS ALKS ALKS 2,116,275 $66.2m0.27% 0.27% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.8m, Q2 2023 2.1m -665.6k -665,642 -23.9%
69 DELL TECHNOLOGIES INC CL C DELL DELL 1,215,208 $65.8m0.27% 0.27% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.1m, Q2 2023 1.2m +120.8k +120,814 11.0%
70 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 2,962,555 $63.9m0.26% 0.26% UnchangedShares held: Q3 2022 5.8m, Q4 2022 4.6m, Q1 2023 3.0m, Q2 2023 3.0m
71 VIKING THERAPEUTICS INC COM VKTX VKTX 3,544,506 $57.5m0.24% 0.24% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.0m, Q2 2023 3.5m +1.6m +1,589,443 81.3%
72 GUARDANT HEALTH INC COM GH GH 1,594,326 $57.1m0.23% 0.23% ReducedShares held: Q3 2022 3.8m, Q4 2022 4.1m, Q1 2023 2.5m, Q2 2023 1.6m -944.6k -944,563 -37.2%
73 PROGRESSIVE CORP COM PGR PGR 396,437 $52.5m0.21% 0.21% ReducedShares held: Q3 2022 736.6k, Q4 2022 336.9k, Q1 2023 1.0m, Q2 2023 396.4k -607.1k -607,125 -60.5%
74 PHARVARIS N V COM PHVS PHVS 3,231,923 $50.8m0.21% 0.21% UnchangedShares held: Q3 2022 2.5m, Q4 2022 3.2m, Q1 2023 3.2m, Q2 2023 3.2m
75 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 5,943,261 $46.1m0.19% 0.19% AddedShares held: Q3 2022 4.4m, Q4 2022 4.4m, Q1 2023 4.9m, Q2 2023 5.9m +1.0m +1,034,115 21.1%
76 ZOOMINFO TECHNOLOGIES INC COMMON STOCK GTM GTM 1,234,538 $31.3m0.13% 0.13% ReducedShares held: Q3 2022 2.5m, Q4 2022 0, Q1 2023 6.7m, Q2 2023 1.2m -5.4m -5,432,038 -81.5%
77 DAY ONE BIOPHARMACEUTICALS I COM COM 2,558,563 $30.5m0.13% 0.13% AddedShares held: Q3 2022 1.6m, Q4 2022 1.6m, Q1 2023 1.6m, Q2 2023 2.6m +1.0m +1,000,000 64.2%
78 TENET HEALTHCARE CORP COM NEW THC THC 363,800 $29.6m0.12% 0.12% NewShares held: Q3 2022 383.5k, Q4 2022 0, Q1 2023 0, Q2 2023 363.8k
79 FARFETCH LTD ORD SH CL A FTCHQ FTCHQ 4,769,602 $28.8m0.12% 0.12% ReducedShares held: Q3 2022 0, Q4 2022 6.8m, Q1 2023 7.1m, Q2 2023 4.8m -2.3m -2,333,855 -32.9%
80 RALLYBIO CORP COM COM 4,194,777 $23.7m0.10% 0.10% UnchangedShares held: Q3 2022 4.2m, Q4 2022 4.2m, Q1 2023 4.2m, Q2 2023 4.2m
81 VERASTEM INC COM NEW VSTM VSTM 1,886,292 $14.0m0.06% 0.06% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.9m
82 PEPGEN INC COM PEPG PEPG 1,482,434 $13.3m0.05% 0.05% ReducedShares held: Q3 2022 1.8m, Q4 2022 1.5m, Q1 2023 1.5m, Q2 2023 1.5m -62.2k -62,197 -4.0%
83 TREVI THERAPEUTICS INC COM TRVI TRVI 4,400,000 $10.5m0.04% 0.04% UnchangedShares held: Q3 2022 4.4m, Q4 2022 4.4m, Q1 2023 4.4m, Q2 2023 4.4m
84 LIANBIO SPONSORED ADS LIANY LIANY 3,564,173 $8.1m0.03% 0.03% UnchangedShares held: Q3 2022 3.6m, Q4 2022 3.6m, Q1 2023 3.6m, Q2 2023 3.6m
85 C3 AI INC CL A AI AI 179,653 $6.5m0.03% 0.03% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 179.7k
86 KINNATE BIOPHARMA INC COM KNTE KNTE 1,820,462 $5.5m0.02% 0.02% UnchangedShares held: Q3 2022 1.8m, Q4 2022 1.8m, Q1 2023 1.8m, Q2 2023 1.8m

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
BLOCK INC XYZ XYZ 2,354,123 $161.6m2.4m shares
MOLINA HEALTHCARE INC MOH MOH 594,553 $159.0m594.6k shares
EQUITABLE HLDGS INC EQH EQH 3,989,446 $101.3m4.0m shares
INSPIRE MED SYS INC INSP INSP 346,576 $81.1m346.6k shares
CHARLES RIV LABS INTL INC CRL CRL 394,089 $79.5m394.1k shares
CATALENT INC CTLT CTLT 1,201,210 $78.9m1.2m shares
TRAVELERS COMPANIES INC TRV TRV 378,345 $64.9m378.3k shares
SNOWFLAKE INC SNOW SNOW 382,757 $59.1m382.8k shares
INTELLIA THERAPEUTICS INC NTLA NTLA 1,569,545 $58.5m1.6m shares
BOSTON SCIENTIFIC CORP BSX BSX 1,136,881 $56.9m1.1m shares
MARSH & MCLENNAN COS INC MRSH MRSH 257,443 $42.9m257.4k shares
OPTION CARE HEALTH INC OPCH OPCH 1,090,497 $34.6m1.1m shares
TJX COS INC NEW TJX TJX 414,401 $32.5m414.4k shares
TALARIS THERAPEUTICS INC 3,289,617 $6.2m3.3m shares
FIRST REP BK SAN FRANCISCO C FRCB FRCB 276,260 $3.9m276.3k shares
VERASTEM INC 9,224,000 $3.8m9.2m shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
CAZOO GROUP LTD CZOOF · 13D · filed 2025-03-12 CZOOF 43.8% 13D 2025-03-12
ADAPTIVE BIOTECHNOLOGIES COR ADPT · 13G · filed 2026-05-15 ADPT 18.8%≈ $643.4m 13G 2026-05-15
TIC SOLUTIONS INC TIC · 13G · filed 2026-05-15 TIC 16.2%≈ $289.8m 13G 2026-05-15
STANDARD BIOTOOLS INC LAB · 13D · filed 2026-06-12 LAB 15.0%≈ $48.3m no change 13D 2026-06-12
RALLYBIO CORP RLYB · 13G · filed 2026-05-15 RLYB 10.0%≈ $8.5m 13G 2026-05-15
RALLYBIO CORP 13G · filed 2026-02-17 10.0% 13G 2026-02-17
INHIBRX BIOSCIENCES INC INBX · 13G · filed 2026-08-14 INBX 9.3%≈ $131.1m -0.7 pts 13G 2026-08-14
ORIC PHARMACEUTICALS INC ORIC · 13G · filed 2026-05-15 ORIC 7.8%≈ $89.5m -2.2 pts 13G 2026-05-15
GINKGO BIOWORKS HOLDINGS INC DNA · 13G · filed 2026-05-15 DNA 7.1%≈ $35.4m 13G 2026-05-15
SIONNA THERAPEUTICS INC SION · 13G · filed 2026-05-15 SION 7.1%≈ $140.6m +0.4 pts 13G 2026-05-15
FORTIVE CORP FTV · 13G · filed 2026-05-15 FTV 7.1%≈ $1.4bn +0.7 pts 13G 2026-05-15
ALTIMMUNE INC ALT · 13G · filed 2026-05-01 ALT 6.7%≈ $40.7m new 13G 2026-05-01
PHARVARIS N V PHVS · 13G · filed 2026-05-15 PHVS 5.6%≈ $126.3m 13G 2026-05-15
REGAL REXNORD CORPORATION RRX · 13G · filed 2026-09-16 RRX 5.4%≈ $852.4m +0.4 pts 13G 2026-09-16
ARTIVA BIOTHERAPEUTICS INC ARTV · 13G · filed 2026-05-18 ARTV 5.4%≈ $25.3m new 13G 2026-05-18
LENNOX INTL INC LII · 13G · filed 2026-04-22 LII 5.2%≈ $1.0bn new 13G 2026-04-22
MID-AMER APT CMNTYS INC MAA · 13G · filed 2026-10-05 MAA 5.1%≈ $817.8m new 13G 2026-10-05
PEPGEN INC PEPG · 13G · filed 2026-05-15 PEPG 5.0%≈ $6.3m -0.1 pts 13G 2026-05-15
BRIDGEBIO PHARMA INC BBIO · 13D · filed 2026-07-10 BBIO 5.0%≈ $729.3m -1.1 pts 13D 2026-07-10

Trades reported as a company insider in Q2 2023

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2023-06-22 ROIVANT SCIENCES LTD 10% owner · See Explanation of Responses ROIV Sold 13,000,000 $128.7m13.0m shares -50%
2023-05-09 4D MOLECULAR THERAPEUTICS IN 10% owner · See Explanation Responses FDMT Bought 850,000 $13.6m850.0k shares +22%